First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

Eur Respir J. 2016 Sep;48(3):935-8. doi: 10.1183/13993003.00637-2016. Epub 2016 Jun 10.

¹ Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy These authors contributed equally.
² Delek Hospital, Dharamshala, India These authors contributed equally.
³ Division of Infection, Barts Health NHS Trust, London, UK These authors contributed equally.
⁴ Amity Health Consortium, Johannesburg, South Africa These authors contributed equally.
⁵ Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland These authors contributed equally.
⁶ Delek Hospital, Dharamshala, India.
⁷ Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
⁸ Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy giovannibattista.migliori@fsm.it.

Abstract

Report of the first case, concerns and challenges of treatment of severe XDR-TB with both delamanid and bedaquiline http://ow.ly/WzeB3004Cmo